Semler Scientific, Inc.

Total Valuation

Semler Scientific, Inc. carries a market capitalization of 310.75M, placing it among publicly traded companies globally. Its enterprise value stands at 437.79M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Semler Scientific, Inc. currently has 15.14M shares outstanding.

Valuation Ratios

Semler Scientific, Inc. trades at a trailing price-to-earnings ratio of 6.86. The price-to-sales ratio is 8.97, and the price-to-book ratio stands at 2.77.

Enterprise Valuation

On an enterprise value basis, Semler Scientific, Inc. trades at an EV/EBITDA multiple of 147.33 and an EV/FCF ratio of 1.14. The EV/Sales ratio of 11.85 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 157.66 provides insight into valuation relative to core operating earnings.

Financial Position

Semler Scientific, Inc. maintains a current ratio of 1.97, meaning it holds 2.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 25.32, indicating elevated leverage, while an interest coverage ratio of -5.13 demonstrates limited ability to service its debt obligations.

Financial Efficiency

Semler Scientific, Inc. posts a return on equity of 50.52 and a return on invested capital of -1.23.

Taxes

Over the trailing twelve months, Semler Scientific, Inc. has paid 13.73M in income taxes, reflecting an effective tax rate of 22.13.

Stock Price Statistics

Semler Scientific, Inc.'s stock has declined approximately -59.91719% over the past 52 weeks. The 50-day moving average sits at 20.31, while the 200-day moving average is 30.26.

Income Statement

Over the trailing twelve months, Semler Scientific, Inc. generated 36.96M in revenue and converted that into 48.34M in net income, yielding earnings per share of 4.01. EBITDA reached -4.84M, while operating income came in at -5.25M.

Balance Sheet

Semler Scientific, Inc. holds 10.18M in cash and equivalents against 116.42M in total debt, resulting in a net debt position of 106.24M. Total book value stands at 119.85M, with working capital of 26.29M providing operational flexibility.

Cash Flow

Semler Scientific, Inc. produced -26.91M in operating cash flow over the past twelve months. After subtracting -410.78M in capital expenditures, free cash flow totaled -437.69M - equivalent to -39.60 per share.

Margins

Semler Scientific, Inc. operates with a gross margin of 90.76, reflecting its pricing power and cost economics. The operating margin of -14.21 and net profit margin of 130.80 provide insight into operational efficiency.

Dividends & Yields

Scores

Semler Scientific, Inc. posts an Altman Z-Score of 5.31, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.